Tango Therapeutics Inc (TNGX) Stock Analysis

Tango Therapeutics Inc (TNGX) is a publicly traded company in the HEALTHCARE sector. It trades at $21.50, carries a market capitalization of $3.18B. This page summarizes the public market data, fundamentals, and frequently asked questions for TNGX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $21.50
• Market Cap: $3.18B
• EPS: $-0.83
• 52-Week High: $28.41
• 52-Week Low: $2.96

Market Sentiment

Tango Therapeutics Inc currently has a Bearish sentiment score of -0.29.

About Tango Therapeutics Inc

None

GNG Research Analysis

GNG Research scores Tango Therapeutics Inc (TNGX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TNGX.

Frequently Asked Questions

Does TNGX pay dividends?

Tango Therapeutics Inc (TNGX) does not currently pay a regular dividend.

What is TNGX's market cap?

Tango Therapeutics Inc (TNGX) has a market capitalization of $3.18B with a current stock price of $21.50.